Cargando…
Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805134/ https://www.ncbi.nlm.nih.gov/pubmed/35105913 http://dx.doi.org/10.1038/s41598-022-05835-2 |
| _version_ | 1784643181358350336 |
|---|---|
| author | Hassanipour, Soheil Arab-Zozani, Morteza Amani, Bahman Heidarzad, Forough Fathalipour, Mohammad Martinez-de-Hoyo, Rudolph |
| author_facet | Hassanipour, Soheil Arab-Zozani, Morteza Amani, Bahman Heidarzad, Forough Fathalipour, Mohammad Martinez-de-Hoyo, Rudolph |
| author_sort | Hassanipour, Soheil |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8805134 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88051342022-02-01 Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials Hassanipour, Soheil Arab-Zozani, Morteza Amani, Bahman Heidarzad, Forough Fathalipour, Mohammad Martinez-de-Hoyo, Rudolph Sci Rep Addendum Nature Publishing Group UK 2022-02-01 /pmc/articles/PMC8805134/ /pubmed/35105913 http://dx.doi.org/10.1038/s41598-022-05835-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Addendum Hassanipour, Soheil Arab-Zozani, Morteza Amani, Bahman Heidarzad, Forough Fathalipour, Mohammad Martinez-de-Hoyo, Rudolph Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials |
| title | Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials |
| title_full | Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials |
| title_fullStr | Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials |
| title_full_unstemmed | Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials |
| title_short | Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials |
| title_sort | addendum: the efficacy and safety of favipiravir in treatment of covid-19: a systematic review and meta-analysis of clinical trials |
| topic | Addendum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805134/ https://www.ncbi.nlm.nih.gov/pubmed/35105913 http://dx.doi.org/10.1038/s41598-022-05835-2 |
| work_keys_str_mv | AT hassanipoursoheil addendumtheefficacyandsafetyoffavipiravirintreatmentofcovid19asystematicreviewandmetaanalysisofclinicaltrials AT arabzozanimorteza addendumtheefficacyandsafetyoffavipiravirintreatmentofcovid19asystematicreviewandmetaanalysisofclinicaltrials AT amanibahman addendumtheefficacyandsafetyoffavipiravirintreatmentofcovid19asystematicreviewandmetaanalysisofclinicaltrials AT heidarzadforough addendumtheefficacyandsafetyoffavipiravirintreatmentofcovid19asystematicreviewandmetaanalysisofclinicaltrials AT fathalipourmohammad addendumtheefficacyandsafetyoffavipiravirintreatmentofcovid19asystematicreviewandmetaanalysisofclinicaltrials AT martinezdehoyorudolph addendumtheefficacyandsafetyoffavipiravirintreatmentofcovid19asystematicreviewandmetaanalysisofclinicaltrials |